Producing high quality purified membrane proteins for structure-based drug design and biophysical assays compatible with typical timelines in drug discovery is a significant challenge. Escherichia coli has been an expression host of the utmost importance for soluble proteins and has applications for membrane proteins as well. However, membrane protein overexpression in E. coli may lead to toxicity and low yields of functional product. Here, we review the challenges encountered with heterologous overproduction of α-helical membrane proteins in E. coli and a range of strategies to overcome them. A detailed protocol is also provided for expression and screening of membrane proteins in E. coli using a Hisspecific fluorescent probe and fluorescent size-exclusion chromatography.
CITATION STYLE
Snijder, H. J. A., & Hakulinen, J. (2016). Membrane protein production in E. coli for applications in drug discovery. In Advances in Experimental Medicine and Biology (Vol. 896, pp. 59–77). Springer New York LLC. https://doi.org/10.1007/978-3-319-27216-0_5
Mendeley helps you to discover research relevant for your work.